Seeking Alpha

More on Trinity Biotech Q2 results

  • Trinity Biotech (TRIB +0.7%) Q2 results: Revenues: $26.0M (+22.1%); Operating Income: $4.6M (+24.3%); Net Income: $4.3M (+13.2%); Earnings per ADR: $0.182 (+7.7%); Quick Assets: $15.2M (-10.6%); CF Ops: $1.6M (-23.8%).
  • 106 Premier instruments placed or sold, 207 in 1H. FY Goal: 460.
  • No guidance given.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector